BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31937561)

  • 21. Lack of Mutations in POT1 Gene in Selected Families with Familial Non-Medullary Thyroid Cancer.
    Orois A; Badenas C; Reverter JL; López V; Potrony M; Mora M; Halperin I; Oriola J
    Horm Cancer; 2020 Apr; 11(2):111-116. PubMed ID: 32172474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The enigma of excessively long telomeres in cancer: lessons learned from rare human POT1 variants.
    Gong Y; Stock AJ; Liu Y
    Curr Opin Genet Dev; 2020 Feb; 60():48-55. PubMed ID: 32155570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer-associated POT1 mutations lead to telomere elongation without induction of a DNA damage response.
    Kim WT; Hennick K; Johnson J; Finnerty B; Choo S; Short SB; Drubin C; Forster R; McMaster ML; Hockemeyer D
    EMBO J; 2021 Jun; 40(12):e107346. PubMed ID: 33934394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A
    Abu Shtaya A; Kedar I; Bazak L; Basel-Salmon L; Barhom SF; Naftali M; Eskin-Schwartz M; Birk OS; Polager-Modan S; Keidar N; Reznick Levi G; Levi Z; Yablonski-Peretz T; Mahamid A; Segol O; Matar R; Bareli Y; Azoulay N; Goldberg Y
    Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. POT1 loss-of-function variants predispose to familial melanoma.
    Robles-Espinoza CD; Harland M; Ramsay AJ; Aoude LG; Quesada V; Ding Z; Pooley KA; Pritchard AL; Tiffen JC; Petljak M; Palmer JM; Symmons J; Johansson P; Stark MS; Gartside MG; Snowden H; Montgomery GW; Martin NG; Liu JZ; Choi J; Makowski M; Brown KM; Dunning AM; Keane TM; López-Otín C; Gruis NA; Hayward NK; Bishop DT; Newton-Bishop JA; Adams DJ
    Nat Genet; 2014 May; 46(5):478-481. PubMed ID: 24686849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia.
    Ramsay AJ; Quesada V; Foronda M; Conde L; Martínez-Trillos A; Villamor N; Rodríguez D; Kwarciak A; Garabaya C; Gallardo M; López-Guerra M; López-Guillermo A; Puente XS; Blasco MA; Campo E; López-Otín C
    Nat Genet; 2013 May; 45(5):526-30. PubMed ID: 23502782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. POT1 tumour predisposition: a broader spectrum of associated malignancies and proposal for additional screening program.
    Baptista Freitas M; Desmyter L; Badoer C; Smits G; Vandernoot I; T Kint de Roodenbeke D
    Eur J Hum Genet; 2024 Jun; ():. PubMed ID: 38839987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Gln94Glu mutation on the structure and function of protection of telomere 1, a cause of cutaneous familial melanoma.
    Amir M; Ahmad S; Ahamad S; Kumar V; Mohammad T; Dohare R; Alajmi MF; Rehman T; Hussain A; Islam A; Ahmad F; Hassan MI
    J Biomol Struct Dyn; 2020 Mar; 38(5):1514-1524. PubMed ID: 31014199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A mouse model for Li-Fraumeni-Like Syndrome with cardiac angiosarcomas associated to POT1 mutations.
    Martínez P; Sánchez-Vázquez R; Ferrara-Romeo I; Serrano R; Flores JM; Blasco MA
    PLoS Genet; 2022 Jun; 18(6):e1010260. PubMed ID: 35727838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Germ line mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia.
    Speedy HE; Kinnersley B; Chubb D; Broderick P; Law PJ; Litchfield K; Jayne S; Dyer MJS; Dearden C; Follows GA; Catovsky D; Houlston RS
    Blood; 2016 Nov; 128(19):2319-2326. PubMed ID: 27528712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.
    Shi J; Yang XR; Ballew B; Rotunno M; Calista D; Fargnoli MC; Ghiorzo P; Bressac-de Paillerets B; Nagore E; Avril MF; Caporaso NE; McMaster ML; Cullen M; Wang Z; Zhang X; ; ; ; Bruno W; Pastorino L; Queirolo P; Banuls-Roca J; Garcia-Casado Z; Vaysse A; Mohamdi H; Riazalhosseini Y; Foglio M; Jouenne F; Hua X; Hyland PL; Yin J; Vallabhaneni H; Chai W; Minghetti P; Pellegrini C; Ravichandran S; Eggermont A; Lathrop M; Peris K; Scarra GB; Landi G; Savage SA; Sampson JN; He J; Yeager M; Goldin LR; Demenais F; Chanock SJ; Tucker MA; Goldstein AM; Liu Y; Landi MT
    Nat Genet; 2014 May; 46(5):482-6. PubMed ID: 24686846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Telomere maintenance and the etiology of adult glioma.
    Walsh KM; Wiencke JK; Lachance DH; Wiemels JL; Molinaro AM; Eckel-Passow JE; Jenkins RB; Wrensch MR
    Neuro Oncol; 2015 Nov; 17(11):1445-52. PubMed ID: 26014050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole exome sequencing identified a novel
    Li Y; Xie Y; Wang D; Xu H; Ye J; Yin JC; Chen J; Yan J; Ye B; Chen C
    Front Oncol; 2022; 12():963364. PubMed ID: 36387164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. POT1 and Damage Response Malfunction Trigger Acquisition of Somatic Activating Mutations in the VEGF Pathway in Cardiac Angiosarcomas.
    Calvete O; Garcia-Pavia P; Domínguez F; Mosteiro L; Pérez-Cabornero L; Cantalapiedra D; Zorio E; Ramón Y Cajal T; Crespo-Leiro MG; Teulé Á; Lázaro C; Morente MM; Urioste M; Benitez J
    J Am Heart Assoc; 2019 Sep; 8(18):e012875. PubMed ID: 31510873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of POT1 in Human Cancer.
    Wu Y; Poulos RC; Reddel RR
    Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32987645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Germline Mutation in the
    Srivastava A; Miao B; Skopelitou D; Kumar V; Kumar A; Paramasivam N; Bonora E; Hemminki K; Försti A; Bandapalli OR
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32492864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pot1 OB-fold mutations unleash telomere instability to initiate tumorigenesis.
    Gu P; Wang Y; Bisht KK; Wu L; Kukova L; Smith EM; Xiao Y; Bailey SM; Lei M; Nandakumar J; Chang S
    Oncogene; 2017 Apr; 36(14):1939-1951. PubMed ID: 27869160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Germline mutations in Protection of Telomeres 1 in two families with Hodgkin lymphoma.
    McMaster ML; Sun C; Landi MT; Savage SA; Rotunno M; Yang XR; Jones K; Vogt A; Hutchinson A; Zhu B; Wang M; Hicks B; Thirunavukarason A; Stewart DR; Koutros S; Goldstein AM; Chanock SJ; Caporaso NE; Tucker MA; Goldin LR; Liu Y
    Br J Haematol; 2018 May; 181(3):372-377. PubMed ID: 29693246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Germline Variants in the POT1-Gene in High-Risk Melanoma Patients in Austria.
    Müller C; Krunic M; Wendt J; von Haeseler A; Okamoto I
    G3 (Bethesda); 2018 May; 8(5):1475-1480. PubMed ID: 29523635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. POT1 Regulates Proliferation and Confers Sexual Dimorphism in Glioma.
    Jalali A; Yu K; Beechar V; Bosquez Huerta NA; Grichuk A; Mehra D; Lozzi B; Kong K; Scott KL; Rao G; Bainbridge MN; Bondy ML; Deneen B
    Cancer Res; 2021 May; 81(10):2703-2713. PubMed ID: 33782098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.